Showing results (351-360 of 1,003) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|June 18, 2010
Aspirin resistance and compliance with therapyJesse Dawson, Terry Quinn, Mark Rafferty, et al.Cardiovascular Therapeutics|June 18, 2010
Oxidative stress impairs endothelial function in nondipper hypertensive patientsRaffaele Maio, Maria Perticone, Angela Sciacqua, et al.Cardiovascular Therapeutics|June 18, 2010
Regression of cardiac valvulopathy related to ergot-derived dopamine agonistsRenzo Zanettini, Angelo Antonini, Gemma Gatto, et al.Cardiovascular Therapeutics|September 3, 2011
Interventional treatments for hypertrophic cardiomyopathySaidi A Mohiddin, Charles KnightCardiovascular Therapeutics|September 3, 2011
Two coronary "orphan" diseases in search of clinical consideration: coronary syndromes x and yTommaso Gori, Massimo FineschiCardiovascular Therapeutics|September 3, 2011
Microembolic signals and aspirin resistance in patients with carotid stenosisJesse Dawson, Terry Quinn, Kennedy R Lees, et al.Cardiovascular Therapeutics|September 3, 2011
Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?Balazs Debreceni, Laszlo DebreceniCardiovascular Therapeutics|September 3, 2011
Overexpression of vasostatin-1 protects hypoxia/reoxygenation injuries in cardiomyocytes independent of endothelial cellsMin Yu, Zheng Wang, Yue Fang, et al.Cardiovascular Therapeutics|September 3, 2011
Ginsenoside Re: pharmacological effects on cardiovascular systemLu Peng, Shi Sun, Lai-Hua Xie, et al.Cardiovascular Therapeutics|September 3, 2011
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular diseaseKerstin Wustmann, Marco Klaey, Annika Burow, et al.Pageof 101